Status:
COMPLETED
Blood Samples to Evaluate Biomarkers of Donor Chimerism
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Leukemia
Hodgkins Disease
Eligibility:
All Genders
18+ years
Brief Summary
We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with a hematologic disease or malignancy
- Scheduled to receive nonablative conditioning with fludarabine and total body irradiation
- Donor is well-matched by high resolution DNA techniques.
- Scheduled to receive postgrafting immunosuppression of oral MMF (CellCept) and an oral calcineurin inhibitor.
- Age \>18 years at the time of enrollment.
- Exclusion criteria:
- Diagnosed with an immunodeficiency disorder
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00764829
Start Date
September 1 2008
End Date
February 1 2012
Last Update
February 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109